RVNC - Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet | Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday.
The Dow traded down 0.69% to 34,384.29 while the NASDAQ fell 0.82% to 13,597.78. The S&P 500 also fell, dropping, 0.63% to 4,425.66.
Check This Out: Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Leading and Lagging Sectors
Utilities shares fell by just 0.2% on Tuesday.
In trading on Tuesday, consumer discretionary shares dipped by 1.4%.
Top Headline
Housing starts in the U.S. fell 11.3% month-over-month to an annualized rate of 1.283 million in August, recording the lowest level since June 2020.
Equities Trading UP
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) shares shot up 17% to $9.86. The FDA granted an investigational device exemption to initiate BACKBEAT Study evaluating Orchestra biomed's atrioventricular interval modulation therapy (BACKBEAT CNT) for hypertensive patients who are indicated for a dual-chamber cardiac pacemaker.
Shares of Avinger, Inc. (NASDAQ: AVGR) got a boost, shooting 62% to $9.83, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
Elutia Inc. (NASDAQ: ELUT) shares were also up, gaining 29% ...